This document discusses a case study of a patient with complex cardiopulmonary issues. The patient presented with COPD exacerbation and was found to have pulmonary hypertension. Initial right heart catheterization found severely elevated pulmonary pressures and pulmonary vascular resistance. After treatment with diuresis and initiation of CPAP, a second catheterization found improved pressures. The document analyzes whether the patient's condition represents pulmonary arterial hypertension alone or a combination of pre-capillary and post-capillary pulmonary hypertension based on the various comorbidities and hemodynamic data. It also discusses challenges in categorizing patients who do not neatly fit classification criteria.
10 Take-home messages of the 2022 ESC/ERS Guidelines for the diagnosis and ...magdyelmasry3
Hemodynamic classification of pulmonary hypertension
Three categories of PH:
pre-capillary (Pre-PH),
combined pre-and-post capillary (Cpc-PH),
and isolated post-capillary (Ipc-PH).unexplained dyspnea or signs/symptoms suggesting PH .3 different drug classes
Nitric Oxide Pathway( PDE-5is and sGCs ).PAH (without cardiopulmonary comorbidities and non-vasoresponders
Endothelin Pathway( ERA )
Prostacyclin Pathway( PCA & PRA )Comprehensive risk assessment in PAH
10 Take-home messages of the 2022 ESC/ERS Guidelines for the diagnosis and ...magdyelmasry3
Hemodynamic classification of pulmonary hypertension
Three categories of PH:
pre-capillary (Pre-PH),
combined pre-and-post capillary (Cpc-PH),
and isolated post-capillary (Ipc-PH).unexplained dyspnea or signs/symptoms suggesting PH .3 different drug classes
Nitric Oxide Pathway( PDE-5is and sGCs ).PAH (without cardiopulmonary comorbidities and non-vasoresponders
Endothelin Pathway( ERA )
Prostacyclin Pathway( PCA & PRA )Comprehensive risk assessment in PAH
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
1. PH in the Real World
Case Studies
Terry Fortin MD
Duke Pulmonary Vascular Disease Center
November 4, 2022
2. • Mean PAP > 20 mmHg
1
• Wedge < 15 mmHg
2
• PVR > 3 WU (or less)
3
Definition of PAH Clinical, Hemodynamic
6th World Symposium 2018
6th World Symposium on PH 2018
3. Groups of PH (Framework)
1. Pulmonary Arterial Hypertension (PAH)
2. PH owing to left heart disease
3. PH owing to lung diseases and/or
hypoxia
4. Chronic thromboembolic pulmonary
hypertension (CTEPH)
5. PH with unclear multifactorial mechanisms
(ESRD, Cancer, Hemoglobinopathy, Sarcoid…
4. Real World : PH or PAH ?
54 yo sickle cell/thallasemia Hgb 7-8
Rheumatoid arthritis SLE overlap/MCTD
CKD on hemodialysis (high output)
History Mitral Valve replacement for remote
endocarditis
Morbid obesity, (BMI>50) OSA on CPAP
LV EF is 45%, HTN, DM, TIA, CAD
Pulmonary embolus x 2 but VQ neg
PFDs with moderate restrictive/ obstructive
lung disease.
Later develops cirrhosis
5. WCM How did we get from A
to B. What if B came first?
RH Cath 4/22
RA 22
RV 110/20
PA 104/45 mean 68
PCWP 28
Output 7 L/min
Index 3.2
PVR 5.7 WU
ABG 7.25/90/107
Hgb 17.9
RH Cath 7/22
RA 8
RV 50/10
PA 52/29 mean 34
Wedge 14
output 5.2 L/min
Index 2.5
PVR 3.9
6. WCM 4/2022
65 yo presents to OSH with “COPD flare and NSTEMI”
EMS called nonresponsive, 02 sat 60% Placed on BiPAP
History COPD since 2017, Flare 1-2 times per year . Not on 02
At OSH ABG 7.1/88/124 on 02
Elevated troponins, LFTs, AKI, pBNP 1700, Hgb 18
CT ruled out PE, No pneumonia
History of sleep apnea x years but never used machine
On inhalers for COPD No PFDs
On transfer hypercarbic and hypoxic respiratory failure.
Diuresis, on /off bipap, ABX and Steroids
11. WCM Right and Left Heart Cath 4/2022
Off BIPAP on FI02 30%
RA 22
RV 110/20
PA 104/45 mean 68
PCWP 28
AO 129/80 mean 96
CO 7 L/min CI 3.2
PVR 5.7 WU No Step up to suggest Shunt
7.25/90/107 Hgb 17.9 Sat 95%
Placed back on BIPAP post case
Two vessel CAD TIMI 3 Flow 80% mid LCx,
Tandom 80% RCA proximal and mid lesions
Negative volume about 3 liters+ by this time
12. Pulmonary Vascular Resistance (PVR) increases
with
hypoxemia,
acidosis,
hypercarbia,
increased catacholamines or sympathetic tone
Illness , inflammation,
Thrombosis
Very high or low lung volumes increase PVR
Activation of neurohormones negatively impacts
function of RV as well
Relevant principles
13. Treatment???
Diuresis
Give pulmonary vasodilator (inhaled prostacyclin)
1 and then 2
Diuresis, initiate CPAP/BIPAP/Trilogy
IV Prostacyclin
Dual oral therapy with endothelin antagonist and PDE 5
inhibitor
Repeat Cath before Discharge?
More Work up
CT with No PE, ANA normal, HIV normal, Some ongoing
work up for liver disease
Had stents to his RCA and LCx
14. My Plan
Diuresis
Sent home with Trilogy Machine
02 for exertion Per PT assessment
Shock Liver resolved. AKI resolved
VBG before Discharge 7.43 pC02 48 post using trilogy in
hospital
Follow up with Pulmonologist / Sleep
Seen back in my clinic in 10 Days
Decreased diuretic, pBNP much improved
Feeling best he has been in years
Plan for repeat Right heart cath after on his Sleep machine
for 2 to 3 months as long as he is well
15. WCM 1st clinic visit
PFDs Group 3 Disease
FVC 3.33 L 76%
FEV1 1.28 L 38%
FEV1/FVC 38
FEF25-7% 14%
TLC 110%
RV 178%
DLCO 13.72 52%
Walk is 393 meters (76% predicated)room air
16. WCM RH Cath 7/2022
RA 8, PA 52/29 mean 34, Wedge 14
Cardiac output is 5.2L/min with index of 2.4
PVR is 3.9 WU, SVR 13 with mean BP of 78
TPG 20, DPG 15
pBNP is 148 ( down from 1700)
Previous cath pre trilogy and diuresis
RA 22, Mean PAP 68, wedge 28 (group 2)
17. Passive or Post Capillary pressures cause congestion of
venous bed and passive PH
Increased PA pressure with high wedge normal PVR
Can then have reversible vasoconsttriction
TPG < 12 and /or DPD or DPG <7
Reactive or precapillary PH physiologic/anatomic remodeling of
arterioles to compensate or protect upstream pulmonary
venous changes
PVR>3, TPG >12, DPD or DPG >7
Early may be reversible and more Chronic irreversible
Combined pre and post capillary PH
Group 2 Pulmonary HTN
18. WCM Sep 2022
Normalization of p BNP pBNP 143 ( < 225 normal)
ANA negative, Alpha -1 Antitrypsin normal
Negative VQ
Bicarb decreased from 35 to 27
Work up for Liver Disease /Steatohepatitis
Completed cardiopulmonary Rehab
No Hospitalizations or COPD flares since 4/22
Compliant with CPAP
Set up for echo next visit
19. WCM
What Group At least Group 2 and 3 ?1
Pre and post capillary PH Initially more Pre
TPG 68-28 =44
DPG 45-24 = 11
But high wedge 28
Does it matter that his pH was 7.25, and pC02 90?
Group 3
Sleep issues
COPD ( Would this be different if ILD)
VQ was low probability
20. Patients do NOT always follow the
rules
Cpc PH Combined Pre and post capillary PH
Group 3 and Group 2 risk factors/ disease
IS PAH really PAH?
Relative Severity of each component or factor
Would we think about this differently if the lung
disease was ILD and not COPD.
If the 2nd cath was first cath
If initial wedge was 20 and not 30
21. Does the Data Make Sense
and is Data accurate
Timing of the data
During hospitalization with some concomitant illness
Rapid diuresis and wedge pressure looks OK
Initial CXR suggests otherwise
Re equilibrate
Inconsistencies of data
Echo looks bad Cardiac output is good
CT or other testing suggest other disease process